BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16601258)

  • 21. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
    Holtman JR; Jing X; Wala EP
    Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Balster RL; Beardsley PM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
    Redwine KE; Trujillo KA
    Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antagonism of the NMDA receptor on tolerance to [D-Pen2,D-Pen5]enkephalin, a delta 1-opioid receptor agonist.
    Zhao GM; Bhargava HN
    Peptides; 1996; 17(2):233-36. PubMed ID: 8801526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice.
    Saucier DM; Kavaliers M
    Brain Res; 1994 Feb; 637(1-2):292-6. PubMed ID: 8180809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.
    Juni A; Cai M; Stankova M; Waxman AR; Arout C; Klein G; Dahan A; Hruby VJ; Mogil JS; Kest B
    Anesthesiology; 2010 Jan; 112(1):181-8. PubMed ID: 19996949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
    Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
    Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are glycineB sites involved in the development of morphine tolerance?
    KotliƄska J
    Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
    Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
    J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex chromosome complement affects nociception and analgesia in newborn mice.
    Gioiosa L; Chen X; Watkins R; Umeda EA; Arnold AP
    J Pain; 2008 Oct; 9(10):962-9. PubMed ID: 18635401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
    Popik P; Kozela E
    Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model.
    Neyama H; Dozono N; Ueda H
    J Pharmacol Exp Ther; 2020 Apr; 373(1):103-112. PubMed ID: 31941720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of tolerance to stress-induced analgesia by MK-801 in mice.
    Vaccarino AL; Clavier MC
    Pharmacol Biochem Behav; 1997 Mar; 56(3):435-9. PubMed ID: 9077580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
    Fischer BD; Ward SJ; Henry FE; Dykstra LA
    Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.